1
|
Calheiros-Lobo J, Lucas A, Cunha A, Elias F, Correia J. Cutaneous wound myiasis - A possible infection in developed countries. Semergen 2024; 50:102060. [PMID: 37826927 DOI: 10.1016/j.semerg.2023.102060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2023] [Accepted: 06/28/2023] [Indexed: 10/14/2023]
Affiliation(s)
- J Calheiros-Lobo
- Family Medicine Residents at USF Renascer, ACES Gondomar, Portugal
| | - A Lucas
- Family Medicine Residents at USF Renascer, ACES Gondomar, Portugal.
| | - A Cunha
- Family Medicine Residents at USF Renascer, ACES Gondomar, Portugal
| | - F Elias
- Family Medicine Residents at USF Renascer, ACES Gondomar, Portugal
| | - J Correia
- Family Medicine Residents at USF Renascer, ACES Gondomar, Portugal
| |
Collapse
|
2
|
Bartolacci JG, Behun MN, Warunek JP, Li T, Sahu A, Dwyer GK, Lucas A, Rong J, Ambrosio F, Turnquist HR, Badylak SF. Matrix-bound nanovesicle-associated IL-33 supports functional recovery after skeletal muscle injury by initiating a pro-regenerative macrophage phenotypic transition. NPJ Regen Med 2024; 9:7. [PMID: 38280914 PMCID: PMC10821913 DOI: 10.1038/s41536-024-00346-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2020] [Accepted: 01/04/2024] [Indexed: 01/29/2024] Open
Abstract
Injuries to skeletal muscle are among the most common injuries in civilian and military populations, accounting for nearly 60% of extremity injuries. The standard of care for severe extremity injury has been focused upon limb salvage procedures and the utilization of tissue grafts or orthotics in conjunction with rehabilitation to avoid amputation. Nonetheless, many patients have persistent strength and functional deficits that permanently impact their quality of life. Preclinical and clinical studies have shown that partial restoration of functional skeletal muscle tissue following injury can be achieved by the implantation of a biologic scaffold composed of extracellular matrix (ECM). These favorable outcomes are mediated, at least in part, through local immunomodulation. The mechanisms underlying this immunomodulatory effect, however, are poorly understood. The present study investigates a potential mechanistic driver of the immunomodulatory effects; specifically, the effect of selected ECM components upon inflammation resolution and repair. Results show that the host response to skeletal muscle injury is profoundly altered and functional recovery decreased in il33-/- mice compared to age- and sex-matched wildtype counterparts by 14 days post-injury. Results also show that IL-33, contained within matrix-bound nanovesicles (MBV), supports skeletal muscle regeneration by regulating local macrophage activation toward a pro-remodeling phenotype via canonical and non-canonical pathways to improve functional recovery from injury compared to untreated il33-/- counterparts. Taken together, these data suggest that MBV and their associated IL-33 cargo represent a novel homeostatic signaling mechanism that contributes to skeletal muscle repair.
Collapse
Affiliation(s)
- J G Bartolacci
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
| | - M N Behun
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
| | - J P Warunek
- Departments of Surgery and Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
| | - T Li
- Departments of Surgery and Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
| | - A Sahu
- Department of Physical Medicine and Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, PA, USA
| | - G K Dwyer
- Departments of Surgery and Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
| | - A Lucas
- Departments of Surgery and Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
| | - J Rong
- McGowan Institute for Regenerative Medicine, Pittsburgh, USA
| | - F Ambrosio
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Physical Medicine and Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, PA, USA
- McGowan Institute for Regenerative Medicine, Pittsburgh, USA
| | - H R Turnquist
- Departments of Surgery and Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
- McGowan Institute for Regenerative Medicine, Pittsburgh, USA.
| | - S F Badylak
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.
- Departments of Surgery and Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
- McGowan Institute for Regenerative Medicine, Pittsburgh, USA.
| |
Collapse
|
3
|
El Abdellati K, Lucas A, Perron H, Tamouza R, Nkam I, Richard JR, Fried S, Barau C, Djonouma N, Pinot A, Fourati S, Rodriguez C, Coppens V, Meyer U, Morrens M, De Picker L, Leboyer M. High unrecognized SARS-CoV-2 exposure of newly admitted and hospitalized psychiatric patients. Brain Behav Immun 2023; 114:500-510. [PMID: 37741299 DOI: 10.1016/j.bbi.2023.09.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Revised: 08/28/2023] [Accepted: 09/16/2023] [Indexed: 09/25/2023] Open
Abstract
BACKGROUND Patients with pre-existing mental disorders are at higher risk for SARS-CoV-2 infection and adverse outcomes, and severe mental illness, including mood and psychosis spectrum disorders, is associated with increased mortality risk. Despite their increased risk profile, patients with severe mental illness have been understudied during the pandemic, with limited estimates of exposure in inpatient settings. OBJECTIVE The aim of this study was to describe the SARS-CoV-2 seroprevalence and antibody titers, and pro-inflammatory cytokine concentrations of newly admitted or hospitalized psychiatric inpatients without known history of COVID-19 infection, using robust quantitative multi-antigen assessments, and compare patients' exposure to that of hospital staff. METHODS This multi-centric, cross-sectional study compared SARS-CoV-2 seroprevalence and titers of 285 patients (University Psychiatric Centre Duffel [UPCD] N = 194; Assistance-Publique-Hopitaux de Paris [AP-HP] N = 91), and 192 hospital caregivers (UPCD N = 130; AP-HP N = 62) at two large psychiatric care facilities between January 1st and the May 30th 2021. Serum levels of SARS-CoV-2 antibodies against Spike proteins (full length), spike subunit 1 (S1), spike subunit 2 (S2), spike subunit 1 receptor binding domain (S1-RBD) and Nucleocapsid proteins were quantitatively determined using an advanced capillary Western Blot technique. To assess the robustness of the between-group seroprevalence differences, we performed sensitivity analyses with stringent cut-offs for seropositivity. We also assessed peripheral concentrations of IL-6, IL-8 and TNF-a using ELLA assays. Secondary analyses included comparisons of SARS-CoV-2 seroprevalence and titers between patient diagnostic subgroups, and between newly admitted (hospitalization ≤ 7 days) and hospitalized patients (hospitalization > 7 days) and correlations between serological and cytokines. RESULTS Patients had a significantly higher SARS-CoV-2 seroprevalence (67.85 % [95% CI 62.20-73.02]) than hospital caregivers (27.08% [95% CI 21.29-33.77]), and had significantly higher global SARS-CoV-2 titers (F = 29.40, df = 2, p < 0.0001). Moreover, patients had a 2.51-fold (95% CI 1.95-3.20) higher SARS-CoV-2 exposure risk compared to hospital caregivers (Fisher's exact test, P < 0.0001). No difference was found in SARS-CoV-2 seroprevalence and titers between patient subgroups. Patients could be differentiated most accurately from hospital caregivers by their higher Spike protein titers (OR 136.54 [95% CI 43.08-481.98], P < 0.0001), lower S1 (OR 0.06 [95% CI 0.02-0.15], P < 0.0001) titers and higher IL-6 (OR 3.41 [95% CI 1.73-7.24], P < 0.0001) and TNF-α (OR 34.29 [95% CI 5.00-258.87], P < 0.0001) and lower titers of IL-8 (OR 0.13 [95% CI 0.05-0.30], P < 0.0001). Seropositive patients had significantly higher SARS-COV-2 antibody titers compared to seropositive hospital caregivers (F = 19.53, df = 2, P < 0.0001), while titers were not different in seronegative individuals. Pro-inflammatory cytokine concentrations were not associated with serological status. CONCLUSION Our work demonstrated a very high unrecognized exposure to SARS-CoV-2 among newly admitted and hospitalized psychiatric inpatients, which is cause for concern in the context of highly robust evidence of adverse outcomes following COVID-19 in psychiatric patients. Attention should be directed toward monitoring and mitigating exposure to infectious agents within psychiatric hospitals.
Collapse
Affiliation(s)
- K El Abdellati
- Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium; Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium.
| | - A Lucas
- Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), plateau We-Met, Inserm UMR1297 and Université Paul Sabatier, Toulouse, France
| | - H Perron
- GeNeuro, Plan-les-Ouates, Geneva, Switzerland; Geneuro-Innovation, Lyon, France
| | - R Tamouza
- INSERM U955 IMRB, Translational Neuropsychiatry laboratory, AP-HP, Hôpital Henri Mondor, DMU IMPACT, Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Paris Est Créteil University, Fondation FondaMental, 94010 Créteil, France; ECNP Immuno-NeuroPsychiatry Network
| | - I Nkam
- INSERM U955 IMRB, Translational Neuropsychiatry laboratory, AP-HP, Hôpital Henri Mondor, DMU IMPACT, Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Paris Est Créteil University, Fondation FondaMental, 94010 Créteil, France
| | - J-R Richard
- INSERM U955 IMRB, Translational Neuropsychiatry laboratory, AP-HP, Hôpital Henri Mondor, DMU IMPACT, Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Paris Est Créteil University, Fondation FondaMental, 94010 Créteil, France
| | - S Fried
- Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), plateau We-Met, Inserm UMR1297 and Université Paul Sabatier, Toulouse, France
| | - C Barau
- Plateforme de resources biologiques, Hôpital Universitaire Henri Mondor, Université Paris Est Créteil, Créteil, France
| | - N Djonouma
- Département Hospitalo-Universitaire de psychiatrie et d'addictologie des hopitaux Henri Mondor, Créteil, France
| | - A Pinot
- INSERM U955 IMRB, Translational Neuropsychiatry laboratory, AP-HP, Hôpital Henri Mondor, DMU IMPACT, Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Paris Est Créteil University, Fondation FondaMental, 94010 Créteil, France
| | - S Fourati
- Department of Virology, INSERM U955, Team « Viruses, Hepatology, Cancer », Hôpitaux Universitaires Henri Mondor, Assistance Publique - Hôpitaux de Paris, Créteil, France
| | - C Rodriguez
- Department of Virology, INSERM U955, Team « Viruses, Hepatology, Cancer », Hôpitaux Universitaires Henri Mondor, Assistance Publique - Hôpitaux de Paris, Créteil, France
| | - V Coppens
- Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium; Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium
| | - U Meyer
- ECNP Immuno-NeuroPsychiatry Network; Institute of Pharmacology and Toxicology, University of Zürich-Vetsuisse, Zürich, Switzerland; Neuroscience Center Zürich, Zürich, Switzerland
| | - M Morrens
- Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium; Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium
| | - L De Picker
- Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium; Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium; ECNP Immuno-NeuroPsychiatry Network
| | - M Leboyer
- INSERM U955 IMRB, Translational Neuropsychiatry laboratory, AP-HP, Hôpital Henri Mondor, DMU IMPACT, Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Paris Est Créteil University, Fondation FondaMental, 94010 Créteil, France; ECNP Immuno-NeuroPsychiatry Network
| |
Collapse
|
4
|
Doss DJ, Johnson GW, Narasimhan S, Shless JS, Jiang JW, González HFJ, Paulo DL, Lucas A, Davis KA, Chang C, Morgan VL, Constantinidis C, Dawant BM, Englot DJ. Deep Learning Segmentation of the Nucleus Basalis of Meynert on 3T MRI. AJNR Am J Neuroradiol 2023; 44:1020-1025. [PMID: 37562826 PMCID: PMC10494939 DOI: 10.3174/ajnr.a7950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Accepted: 06/25/2023] [Indexed: 08/12/2023]
Abstract
BACKGROUND AND PURPOSE The nucleus basalis of Meynert is a key subcortical structure that is important in arousal and cognition and has been explored as a deep brain stimulation target but is difficult to study due to its small size, variability among patients, and lack of contrast on 3T MR imaging. Thus, our goal was to establish and evaluate a deep learning network for automatic, accurate, and patient-specific segmentations with 3T MR imaging. MATERIALS AND METHODS Patient-specific segmentations can be produced manually; however, the nucleus basalis of Meynert is difficult to accurately segment on 3T MR imaging, with 7T being preferred. Thus, paired 3T and 7T MR imaging data sets of 21 healthy subjects were obtained. A test data set of 6 subjects was completely withheld. The nucleus was expertly segmented on 7T, providing accurate labels for the paired 3T MR imaging. An external data set of 14 patients with temporal lobe epilepsy was used to test the model on brains with neurologic disorders. A 3D-Unet convolutional neural network was constructed, and a 5-fold cross-validation was performed. RESULTS The novel segmentation model demonstrated significantly improved Dice coefficients over the standard probabilistic atlas for both healthy subjects (mean, 0.68 [SD, 0.10] versus 0.45 [SD, 0.11], P = .002, t test) and patients (0.64 [SD, 0.10] versus 0.37 [SD, 0.22], P < .001). Additionally, the model demonstrated significantly decreased centroid distance in patients (1.18 [SD, 0.43] mm, 3.09 [SD, 2.56] mm, P = .007). CONCLUSIONS We developed the first model, to our knowledge, for automatic and accurate patient-specific segmentation of the nucleus basalis of Meynert. This model may enable further study into the nucleus, impacting new treatments such as deep brain stimulation.
Collapse
Affiliation(s)
- D J Doss
- From the Department of Biomedical Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang., V.L.M., C. Constantinidis, D.J.E.), Vanderbilt University, Nashville, Tennessee
- Institute of Imaging Science (D.J.D., G.W.J., S.N., J.S.S., J.W.J., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Vanderbilt Institute for Surgery and Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Nashville, Tennessee
| | - G W Johnson
- From the Department of Biomedical Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang., V.L.M., C. Constantinidis, D.J.E.), Vanderbilt University, Nashville, Tennessee
- Institute of Imaging Science (D.J.D., G.W.J., S.N., J.S.S., J.W.J., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Vanderbilt Institute for Surgery and Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Nashville, Tennessee
| | - S Narasimhan
- From the Department of Biomedical Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang., V.L.M., C. Constantinidis, D.J.E.), Vanderbilt University, Nashville, Tennessee
- Institute of Imaging Science (D.J.D., G.W.J., S.N., J.S.S., J.W.J., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Vanderbilt Institute for Surgery and Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Nashville, Tennessee
- Department of Neurological Surgery (S.N., J.S.S., J.W.J., D.L.P., V.L.M., D.J.E.), Vanderbilt University Medical Center, Nashville, Tennessee
| | - J S Shless
- Institute of Imaging Science (D.J.D., G.W.J., S.N., J.S.S., J.W.J., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Department of Neurological Surgery (S.N., J.S.S., J.W.J., D.L.P., V.L.M., D.J.E.), Vanderbilt University Medical Center, Nashville, Tennessee
| | - J W Jiang
- Institute of Imaging Science (D.J.D., G.W.J., S.N., J.S.S., J.W.J., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Department of Neurological Surgery (S.N., J.S.S., J.W.J., D.L.P., V.L.M., D.J.E.), Vanderbilt University Medical Center, Nashville, Tennessee
| | - H F J González
- From the Department of Biomedical Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang., V.L.M., C. Constantinidis, D.J.E.), Vanderbilt University, Nashville, Tennessee
- Institute of Imaging Science (D.J.D., G.W.J., S.N., J.S.S., J.W.J., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Vanderbilt Institute for Surgery and Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Nashville, Tennessee
| | - D L Paulo
- Department of Neurological Surgery (S.N., J.S.S., J.W.J., D.L.P., V.L.M., D.J.E.), Vanderbilt University Medical Center, Nashville, Tennessee
| | - A Lucas
- Department of Bioengineering (A.L.), University of Pennsylvania, Philadelphia, Pennsylvania
| | - K A Davis
- Department of Neuroscience (K.A.D.), University of Pennsylvania, Philadelphia, Pennsylvania
- Center for Neuroengineering and Therapeutics (K.A.D.), University of Pennsylvania, Philadelphia, Pennsylvania
- Neurology (K.A.D.), University of Pennsylvania, Philadelphia, Pennsylvania
| | - C Chang
- From the Department of Biomedical Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang., V.L.M., C. Constantinidis, D.J.E.), Vanderbilt University, Nashville, Tennessee
- Institute of Imaging Science (D.J.D., G.W.J., S.N., J.S.S., J.W.J., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Vanderbilt Institute for Surgery and Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Nashville, Tennessee
- Department of Electrical and Computer Engineering (C. Chang, B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Department of Computer Science (C. Chang), Vanderbilt University, Nashville, Tennessee
| | - V L Morgan
- From the Department of Biomedical Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang., V.L.M., C. Constantinidis, D.J.E.), Vanderbilt University, Nashville, Tennessee
- Institute of Imaging Science (D.J.D., G.W.J., S.N., J.S.S., J.W.J., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Vanderbilt Institute for Surgery and Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Nashville, Tennessee
- Department of Neurological Surgery (S.N., J.S.S., J.W.J., D.L.P., V.L.M., D.J.E.), Vanderbilt University Medical Center, Nashville, Tennessee
- Department of Neurology (V.L.M.), Vanderbilt University Medical Center, Nashville, Tennessee
- Department of Radiological Sciences (V.L.M., D.J.E.), Vanderbilt University Medical Center, Nashville, Tennessee
| | - C Constantinidis
- From the Department of Biomedical Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang., V.L.M., C. Constantinidis, D.J.E.), Vanderbilt University, Nashville, Tennessee
- Department of Ophthalmology and Visual Sciences (C. Constantinidis), Vanderbilt University Medical Center, Nashville, Tennessee
- Department of Neuroscience (C. Constantinidis), Vanderbilt University, Nashville, Tennessee
| | - B M Dawant
- Institute of Imaging Science (D.J.D., G.W.J., S.N., J.S.S., J.W.J., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Vanderbilt Institute for Surgery and Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Nashville, Tennessee
- Department of Electrical and Computer Engineering (C. Chang, B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
| | - D J Englot
- From the Department of Biomedical Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang., V.L.M., C. Constantinidis, D.J.E.), Vanderbilt University, Nashville, Tennessee
- Institute of Imaging Science (D.J.D., G.W.J., S.N., J.S.S., J.W.J., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Vanderbilt Institute for Surgery and Engineering (D.J.D., G.W.J., S.N., H.F.J.G., C. Chang, V.L.M., B.M.D., D.J.E.), Nashville, Tennessee
- Department of Neurological Surgery (S.N., J.S.S., J.W.J., D.L.P., V.L.M., D.J.E.), Vanderbilt University Medical Center, Nashville, Tennessee
- Department of Electrical and Computer Engineering (C. Chang, B.M.D., D.J.E.), Vanderbilt University, Nashville, Tennessee
- Department of Radiological Sciences (V.L.M., D.J.E.), Vanderbilt University Medical Center, Nashville, Tennessee
| |
Collapse
|
5
|
Telg S, Dubinova A, Lucas A. Covid-19, credit risk management modeling, and government support. J Bank Financ 2023; 147:106638. [PMID: 36033649 PMCID: PMC9394100 DOI: 10.1016/j.jbankfin.2022.106638] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Accepted: 08/06/2022] [Indexed: 06/15/2023]
Abstract
We investigate rating and default risk dynamics over the covid-19 crisis from a credit risk modeling perspective. We find that growth dynamics remain a stable and sufficient predictor of credit risk incidence over the pandemic period, despite its large, short-lived swings due to government intervention and lockdown. Unobserved component models as used in the recent credit risk literature appear mainly helpful for explaining the high-default wave in the early 2000s, but less so for default prediction above and beyond growth dynamics during the 2008 financial crisis or the early 2020 covid default peak. Government support variables do not reduce the impact of either growth proxies or unobserved components. Correlations between government support and credit risk are different, however, during the financial and the covid crisis. Using the empirical models in this paper as credit risk management tools, we show that growth factors also suffice to predict credit risk quantiles out-of-sample during covid times.
Collapse
Affiliation(s)
- Sean Telg
- Vrije Universiteit Amsterdam, Netherlands
- Tinbergen Institute, Netherlands
| | | | - Andre Lucas
- Vrije Universiteit Amsterdam, Netherlands
- Tinbergen Institute, Netherlands
| |
Collapse
|
6
|
Sánchez-Sánchez JL, Guyonnet S, Lucas A, Parini A, Rolland Y, de Souto Barreto P. Plasma Inflammatory Biomarkers and Anorexia of Ageing among Community-Dwelling Older Adults: An Exploratory Analysis of the MAPT Study. J Nutr Health Aging 2023; 27:1127-1131. [PMID: 37997735 DOI: 10.1007/s12603-023-2024-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Accepted: 10/22/2023] [Indexed: 11/25/2023]
Abstract
Anorexia of aging and biological aging might share physiological underpinnings. The aim of this secondary analysis was to investigate the associations between circulating inflammation-related markers and anorexia of aging in community-dwelling older adults. C-reactive protein (CRP), tumor necrosis factor receptor-1 (TNFR-1), interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1) and growth/differentiation factor-15 (GDF-15) were measured in plasma. Anorexia of aging was defined by the response "severe/moderate decrease in food intake" to the first item of the Mini-Nutritional Assessment. We included 463 subjects (median age=74y, IQR=71-78; 63.1% women). 33 subjects (7.1%) presented with anorexia at baseline, whereas 25 out of 363 (6.9%) developed it along 1-year follow-up. We found that TNFR1 (OR=1.74, 95%CI=1.27-2.39) and GDF-15 (OR=1.38, 95%CI=1.01-1.89) were associated with a significant increase in the odds of presenting with anorexia of aging cross-sectionally. No further significant associations were found. Biological aging mechanisms might be involved in the pathogenesis of anorexia of aging.
Collapse
Affiliation(s)
- J L Sánchez-Sánchez
- Juan Luis Sánchez-Sánchez, CHU Toulouse Gérontopôle: Centre Hospitalier Universitaire de Toulouse Gerontopole, France,
| | | | | | | | | | | |
Collapse
|
7
|
Kawasaki S, Hwang G, Buckner K, Francis E, Huffnagle S, Kraschnewski J, Vulgamore P, Lucas A, Barbour J, Crawford M, Thomas L, Fuller M, Meyers J, Swartzentruber G, Levine R. Collaborative health systems ECHO: The use of a tele-education platform to facilitate communication and collaboration with recipients of state targeted response funds in Pennsylvania. Subst Abuse 2022; 43:892-900. [PMID: 35192446 PMCID: PMC9627399 DOI: 10.1080/08897077.2021.2007519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Background: The opioid epidemic continues to erode communities across Pennsylvania (PA). Federal and PA state programs developed grants to establish Hub and Spoke programs for the expansion of medications for opioid use disorders (MOUD). Employing the telementoring platform Project ECHO (Extension for Community Health Outcomes), Penn State Health engaged the other seven grant awardees in a Collaborative Health Systems (CHS) ECHO. We conducted key informant interviews to better understand impact of the CHS ECHO on health systems collaboration and opioid crisis efforts. Methods: For eight one-hour sessions, each awardee presented their unique strategies, challenges, and opportunities. Using REDCap, program characteristics, such as number of waivered prescribers and number of patients served were collected at baseline. After completion of the sessions, key informant interviews were conducted to assess the impact of CHS ECHO on awardee's programs. Results: Analysis of key informant interviews revealed important themes to address opioid crisis efforts, including the need for strategic and proactive program reevaluation and the convenience of collaborative peer learning networks. Participants expressed benefits of the CHS ECHO including allowing space for discussion of challenges and best practices and facilitating conversation on collaborative targeted advocacy and systems-level improvements. Participants further reported bolstered motivation and confidence. Conclusions: Utilizing Project ECHO provided a bidirectional platform of learning and support that created important connections between institutions working to combat the opioid epidemic. CHS ECHO was a unique opportunity for productive and convenient peer learning across external partners. Open dialogue developed during CHS ECHO can continue to direct systems-levels improvements that benefit individual and population outcomes.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | - L Thomas
- The Wright Center for Community Health
| | | | - J Meyers
- UPMC Center for High Value Health Care
| | | | - R Levine
- Pennsylvania Department of Health
| |
Collapse
|
8
|
Perrin C, Jacob A, Lucas A, Myhill R, Hauber E, Batov A, Gudkova T, Rodriguez S, Lognonné P, Stevanović J, Drilleau M, Fuji N. Geometry and Segmentation of Cerberus Fossae, Mars: Implications for Marsquake Properties. J Geophys Res Planets 2022; 127:e2021JE007118. [PMID: 35847353 PMCID: PMC9285074 DOI: 10.1029/2021je007118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/01/2021] [Revised: 12/20/2021] [Accepted: 01/10/2022] [Indexed: 06/15/2023]
Abstract
The NASA InSight mission to Mars successfully landed on 26 November 2018 in Elysium Planitia. It aims to characterize the seismic activity and aid in the understanding of the internal structure of Mars. We focus on the Cerberus Fossae region, a giant fracture network ∼1,200 km long situated east of the InSight landing site where M ∼3 marsquakes were detected during the past 2 years. It is formed of five main fossae located on the southeast of the Elysium Mons volcanic rise. We perform a detailed mapping of the entire system based on high-resolution satellite images and Digital Elevation Models. The refined cartography reveals a range of morphologies associated with dike activity at depth. Width and throw measurements of the fossae are linearly correlated, suggesting a possible tectonic control on the shapes of the fossae. Widths and throws decrease toward the east, indicating the long-term direction of propagation of the dike-induced graben system. They also give insights into the geometry at depth and how the possible faults and fractures are rooted in the crust. The exceptional preservation of the fossae allows us to detect up to four scales of segmentation, each formed by a similar number of 3-4 segments/subsegments. This generic distribution is comparable to continental faults and fractures on Earth. We anticipate higher stress and potential marsquakes within intersegment zones and at graben tips.
Collapse
Affiliation(s)
- C. Perrin
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
- Now at Nantes UniversitéUniversité d’AngersLe Mans UniversitéCNRS, UMR 6112, Laboratoire de Planétologie et GéosciencesUAR 3281, Observatoire des Sciences de l’Univers de Nantes AtlantiqueNantesFrance
| | - A. Jacob
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
| | - A. Lucas
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
| | - R. Myhill
- School of Earth SciencesUniversity of BristolBristolUK
| | - E. Hauber
- DLR Institute of Planetary ResearchBerlinGermany
| | - A. Batov
- Schmidt Institute of Physics of the EarthRussian Academy of SciencesMoscowRussia
- V.A. Trapeznikov Institute of Control SciencesRussian Academy of SciencesMoscowRussia
| | - T. Gudkova
- Schmidt Institute of Physics of the EarthRussian Academy of SciencesMoscowRussia
| | - S. Rodriguez
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
| | - P. Lognonné
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
| | | | - M. Drilleau
- Institut Supérieur de l’Aéronautique et de l’Espace ISAE‐SUPAEROToulouseFrance
| | - N. Fuji
- Université de ParisInstitut de physique du globe de ParisCNRSParisFrance
| |
Collapse
|
9
|
Helou B, Bel-Brunon A, Dupont C, Ye W, Silvestro C, Rochette M, Lucas A, Kaladji A, Haigron P. The influence of angioplasty balloon sizing on acute post-procedural outcomes: a Finite Element Analysis. Annu Int Conf IEEE Eng Med Biol Soc 2020; 2020:2536-2539. [PMID: 33018523 DOI: 10.1109/embc44109.2020.9176740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Atherosclerosis is one of the most common vascular pathologies in the world. Among the most commonly performed endovascular treatments, percutaneous transluminal angioplasty (PTA) has been showing significantly positive clinical outcomes. Due to the complex geometries, material properties and interactions that characterize PTA procedures, finite element analyses of acute angioplasty balloon deployment are limited. In this work, finite element method (FEM) was used to simulate the inflation and deflation of a semi-compliant balloon within the 3D model of a stenosed artery with two different plaque types (lipid and calcified). Self-defined constitutive models for the balloon and the plaque were developed based on experimental and literature data respectively. Balloon deployment was simulated at three different inflation pressures (10, 12 and 14 atm) within the two plaque types. Balloon sizing influence on the arterial elastic recoil obtained immediately after PTA was then investigated. The simulated results show that calcified plaques may lead to higher elastic recoil ratios compared to lipid stenosis, when the same balloon inflation pressures are applied. Also, elastic recoil increases for higher balloon inflation pressure independent of the plaque type. These findings open the way for a data-driven assessment of angioplasty balloon sizing selection and clinical procedures optimization.Clinical Relevance- The FE model developed in this work aims at providing quantitative evaluation of recoil after balloon angioplasty. It may be useful for both manufacturers and clinicians to improve efficiency of angioplasty balloon device design and sizing selection with respect to plaque geometry and constitution, consequently enhancing clinical outcomes.
Collapse
|
10
|
Maher J, Cruz G, Huang T, Van Ligten M, Lucas A, Prado L, Attiah M, Shirzai S, Chang J, Hari A, Clair K, Tewari K. Compliance with visual inspection with acetic acid (VIA) screening for cervical cancer in northern Tanzania. Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.656] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
11
|
Cooper E, Crawford E, Maher J, Chinn J, Runge A, Bera K, Zezoff D, Dinicu A, Naaseh A, Lucas A, White K, Tewari S, Hari A, Bernstein M, Chang J, Ziogas A, Pearre D, Tewari K. Feasibility Of Visual Inspection With Acetic Acid (VIA) Screening For Cervical Cancer In Tanzania With Emphasis On Baseline Knowledge And Educational Intervention. Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2019.11.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
12
|
Hayes MC, Jourdan SW, Herzog DP, Barnes P, Charan C, Fleeker J, Francis H, Litke DW, Hall C, Luitweiler P, Lucas A, Marti L, Mihaliak C, Mumma R, Spittler T, Strauss J, Thurman EM. Determination of Atrazine in Water by Magnetic Particle Immunoassay: Collaborative Study. J AOAC Int 2020. [DOI: 10.1093/jaoac/79.2.529] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
A collaborative study was performed to determine mean recovery and precision for analysis of atrazine in drinking and surface waters by immunoassay. The study design was based on the blind duplicate test plan for collaborative studies. Three blank waters (municipal drinking water, well water, and surface water) were spiked at 3 atrazine levels. Two water samples with naturally incurred atrazine loads were also spiked with atrazine at 3 levels. In the enzyme-linked immunoassay method, the water sample is mixed with a pesticide–enzyme conjugate and added to paramagnetic particles with triazine-specific antibodies attached. After separation of antibody-bound atrazine and atrazine–enzyme conjugate from free components, the bound enzyme conjugate catalyzes a reaction producing a colored end product. The color developed is inversely proportional to the original concentration of atrazine in the water sample. Fourteen laboratories participated in the collaborative study. Data were analyzed for repeatability and reproducibility, and average recoveries at the spike levels were calculated. Over the concentration range tested, the mean recovery of atrazine spiked into blank and pesticide-contaminated waters was 104%. Overall RSDRaveraged about 40% for atrazine concentrations near the method detection limit (0.05 μg/L) and about 15% at concentrations above 5 times the detection limit (0.25 μg/L). Corresponding single-analyst RSDr values were 24 and 10%. Recovery and precision for the 3 blank water matrixes and the waters that had been naturally contaminated with atrazine showed no significant differences. The magnetic particle immunoassay
Collapse
Affiliation(s)
- Mary C Hayes
- Ohmicron Environmental Diagnostics, 375 Pheasant Run, Newtown, PA 18940
| | - Scott W Jourdan
- Ohmicron Environmental Diagnostics, 375 Pheasant Run, Newtown, PA 18940
| | - David P Herzog
- Ohmicron Environmental Diagnostics, 375 Pheasant Run, Newtown, PA 18940
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Mongay N, Vidal N, Lucas A, Macià M, Plans G, Fernandez-Coello A, Majos C, Rodriguez-Bel L, Alemany M, Bruna J. P14.93 The utility of the brain 18-FDG-PET and perfusion magnetic resonance imaging in the radionecrosis differential diagnosis. Neuro Oncol 2019. [DOI: 10.1093/neuonc/noz126.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
BACKGROUND
Radiation-induced necrosis (RDN) is a side effect observed in patients who underwent stereotactic radiosurgery (SRS) alone or combined with whole brain radiotherapy (WBRT) as treatment for their brain tumors. Nowadays, RDN diagnosis and differentiation from tumor progression using the standard imaging techniques represents a challenge, and histological diagnosis still is the gold standard.Our aim is to assess the positive and negative predictive values (PPV, NPV) of FDG-PET and perfusion magnetic resonance imaging (MRI) in RDN diagnosis.
MATERIAL AND METHODS
From our Pathology department database, all patients with RDN or mixed (tumor plus RDN) brain lesions diagnosis during last 5 years were reviewed. Demographic, clinical and oncologic treatment characteristics were recorded. MRI and FDG-PET images at the suspicion (clinical or radiological) of progression or RDN were registered and compared with the definite diagnosis provided by the tissue sample analysis. Sensitivity, specificity, as such as PPV and NPV for perfusion MRI sequences and FDG-PET image analysis were calculated.
RESULTS
162 patients underwent SRS+/- WBRT in a 5 year period. During follow-up, 11 patients had surgery-confirmed RDN. There are 11 patients (3 women) with 12 lesions, 3 from a breast cancer, 6 from a lung tumor, 1 from a melanoma, 1 atypical meningioma and 1 glioblastoma. 9 of them were treated with both SRS and WBRT, and the 3 others with WBRT alone. The mean age was 65.36 (range: 44–77) years. The median time between the completion of radiation therapy and the suspicion of RDN was 19.7 (range: 3–34) months. With the evolution, it was observed an evident increase in the size of surronding oedema (2–6 times) by FLAIR RMI. We estimate a PPV 0.40 and NPV 0.80 for perfusion MRI, and PPV 0.25 and NPV 0.75 for FDG-PET, respectively.
CONCLUSION
The diagnostic performance of both techniques in our series is low and similar to published data; therefore its results must be carefully interpreted in each case. It is peremptory to implement new diagnostic tools in the standard of care with better diagnostic outcomes.
Collapse
Affiliation(s)
- N Mongay
- Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO, L’Hospitalet, Spain
| | - N Vidal
- Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO, L’Hospitalet, Spain
| | - A Lucas
- Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO, L’Hospitalet, Spain
| | - M Macià
- Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO, L’Hospitalet, Spain
| | - G Plans
- Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO, L’Hospitalet, Spain
| | - A Fernandez-Coello
- Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO, L’Hospitalet, Spain
| | - C Majos
- Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO, L’Hospitalet, Spain
| | - L Rodriguez-Bel
- Department of Nuclear Medicine, Hospital Universitari de Bellvitge, L’Hospitalet, Spain
| | - M Alemany
- Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO, L’Hospitalet, Spain
| | - J Bruna
- Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO, L’Hospitalet, Spain
| |
Collapse
|
14
|
Yaron J, Ambadapadi S, Zhang L, Tibbetts S, Keinan S, Chavan R, Varsani A, Maldonado J, Tafoya A, Bullard W, Kilbourne J, Munk B, Thomas R, Koppang E, Lim E, Lucas A. Gut Microbiota Determine Severity Of Lethal Gammaherpesvirus-Induced Vasculitis And Efficacy Of Immune-Modulating Therapy In Mice. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
15
|
Maher J, Lucas A, Zezoff D, Crawford E, Chang J, Ziogas A, Runge A, Chinn J, Cooper E, Dinicu A, Naaseh A, White K, Bera K, Bernstein M, Hari A, Tewari S, Pearre D, Tewari K. Towards eliminating cervical cancer in East Africa: Feasibility of visual inspection with acetic acid (VIA) screening and immediate cryotherapy in rural and urban Tanzania. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.259] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
16
|
Docampo A, Sánchez-Pujol MJ, Belinchón I, Miralles J, Lucas A, García L, Cuesta L, Berbegal L, Quecedo E, Millan F, Esteve A, Sánchez EM, Díaz T, Bernat J, Betlloch I. Response to Letter to the editor: 'Psoriasis dermatitis: an overlap condition of psoriasis and atopic dermatitis in children'. J Eur Acad Dermatol Venereol 2019; 33:e410-e412. [PMID: 31136030 DOI: 10.1111/jdv.15716] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2019] [Accepted: 05/17/2019] [Indexed: 01/09/2023]
Affiliation(s)
- A Docampo
- Hospital General de Alicante, Alicante, Spain
| | | | - I Belinchón
- Hospital General de Alicante, Alicante, Spain
| | - J Miralles
- Hospital San Juan de Alicante, Alicante, Spain
| | - A Lucas
- Hospital General de Elda, Elda, Spain
| | - L García
- Hospital General de Elda, Elda, Spain
| | - L Cuesta
- Hospital La Marina Baixa, Villajoyosa, Spain
| | | | - E Quecedo
- Hospital Arnau de Vilanova de Valencia, Valencia, Spain
| | - F Millan
- Hospital Arnau de Vilanova de Valencia, Valencia, Spain
| | - A Esteve
- Hospital General de Valencia, Valencia, Spain
| | - E M Sánchez
- Hospital Dr. Peset de Valencia, Valencia, Spain
| | - T Díaz
- Hospital de Requena, Requena, Spain
| | - J Bernat
- Hospital General de Castellón, Castellon de la Plana, Spain
| | - I Betlloch
- Hospital General de Alicante, Alicante, Spain
| |
Collapse
|
17
|
Jaspers J, Mendez Romero A, Hoogeman M, van den Bent M, Wiggenraad R, Taphoorn M, Eekers D, Lagerwaard F, Lucas A, Baumert B, Klein M. The Hippocampal NTCP Model Could Not be Validated Within the EORTC-22033 Low-Grade Glioma Trial. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.06.114] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Alemany M, Domènech M, Vilariño N, Jové M, Brao I, Arellano M, Lucas A, Navarro A, Palmero R, Simó M, Velasco R, Nadal E, Bruna J. P05.21 T1-flair to T1-gadolinium MRI ratio as a predictive value of treatment response in non-small-cell lung cancer (NSCLC) patients affected by multiple brain metastases. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M Alemany
- Neuro-Oncology Unit. Bellvitge University Hospital-ICO, L’Hospitalet, Spain
| | - M Domènech
- Thoracic Oncology Unit. Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Spain
| | - N Vilariño
- Thoracic Oncology Unit. Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Spain
| | - M Jové
- Thoracic Oncology Unit. Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Spain
| | - I Brao
- Thoracic Oncology Unit. Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Spain
| | - M Arellano
- Thoracic Oncology Unit. Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Spain
| | - A Lucas
- Department of Radiation. Catalan Institute of Oncology, L’Hospitalet, Spain
| | - A Navarro
- Department of Radiation. Catalan Institute of Oncology, L’Hospitalet, Spain
| | - R Palmero
- Thoracic Oncology Unit. Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Spain
| | - M Simó
- Neuro-Oncology Unit. Bellvitge University Hospital-ICO, L’Hospitalet, Spain
| | - R Velasco
- Neuro-Oncology Unit. Bellvitge University Hospital-ICO, L’Hospitalet, Spain
| | - E Nadal
- Thoracic Oncology Unit. Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Spain
| | - J Bruna
- Neuro-Oncology Unit. Bellvitge University Hospital-ICO, L’Hospitalet, Spain
| |
Collapse
|
19
|
Blasques F, Koopman SJ, Lucas A. Amendments and Corrections. Biometrika 2018. [DOI: 10.1093/biomet/asy039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
20
|
Tang WW, McGee P, Lachin JM, Li DY, Hoogwerf B, Hazen SL, Nathan D, Zinman B, Crofford O, Genuth S, Brown‐Friday J, Crandall J, Engel H, Engel S, Martinez H, Phillips M, Reid M, Shamoon H, Sheindlin J, Gubitosi‐Klug R, Mayer L, Pendegast S, Zegarra H, Miller D, Singerman L, Smith‐Brewer S, Novak M, Quin J, Genuth S, Palmert M, Brown E, McConnell J, Pugsley P, Crawford P, Dahms W, Gregory N, Lackaye M, Kiss S, Chan R, Orlin A, Rubin M, Brillon D, Reppucci V, Lee T, Heinemann M, Chang S, Levy B, Jovanovic L, Richardson M, Bosco B, Dwoskin A, Hanna R, Barron S, Campbell R, Bhan A, Kruger D, Jones J, Edwards P, Bhan A, Carey J, Angus E, Thomas A, Galprin A, McLellan M, Whitehouse F, Bergenstal R, Johnson M, Gunyou K, Thomas L, Laechelt J, Hollander P, Spencer M, Kendall D, Cuddihy R, Callahan P, List S, Gott J, Rude N, Olson B, Franz M, Castle G, Birk R, Nelson J, Freking D, Gill L, Mestrezat W, Etzwiler D, Morgan K, Aiello L, Golden E, Arrigg P, Asuquo V, Beaser R, Bestourous L, Cavallerano J, Cavicchi R, Ganda O, Hamdy O, Kirby R, Murtha T, Schlossman D, Shah S, Sharuk G, Silva P, Silver P, Stockman M, Sun J, Weimann E, Wolpert H, Aiello L, Jacobson A, Rand L, Rosenzwieg J, Nathan D, Larkin M, Christofi M, Folino K, Godine J, Lou P, Stevens C, Anderson E, Bode H, Brink S, Cornish C, Cros D, Delahanty L, eManbey ., Haggan C, Lynch J, McKitrick C, Norman D, Moore D, Ong M, Taylor C, Zimbler D, Crowell S, Fritz S, Hansen K, Gauthier‐Kelly C, Service F, Ziegler G, Barkmeier A, Schmidt L, French B, Woodwick R, Rizza R, Schwenk W, Haymond M, Pach J, Mortenson J, Zimmerman B, Lucas A, Colligan R, Luttrell L, Lopes‐Virella M, Caulder S, Pittman C, Patel N, Lee K, Nutaitis M, Fernandes J, Hermayer K, Kwon S, Blevins A, Parker J, Colwell J, Lee D, Soule J, Lindsey P, Bracey M, Farr A, Elsing S, Thompson T, Selby J, Lyons T, Yacoub‐Wasef S, Szpiech M, Wood D, Mayfield R, Molitch M, Adelman D, Colson S, Jampol L, Lyon A, Gill M, Strugula Z, Kaminski L, Mirza R, Simjanoski E, Ryan D, Johnson C, Wallia A, Ajroud‐Driss S, Astelford P, Leloudes N, Degillio A, Schaefer B, Mudaliar S, Lorenzi G, Goldbaum M, Jones K, Prince M, Swenson M, Grant I, Reed R, Lyon R, Kolterman O, Giotta M, Clark T, Friedenberg G, Sivitz W, Vittetoe B, Kramer J, Bayless M, Zeitler R, Schrott H, Olson N, Snetselaar L, Hoffman R, MacIndoe J, Weingeist T, Fountain C, Miller R, Johnsonbaugh S, Patronas M, Carney M, Mendley S, Salemi P, Liss R, Hebdon M, Counts D, Donner T, Gordon J, Hemady R, Kowarski A, Ostrowski D, Steidl S, Jones B, Herman W, Martin C, Pop‐Busui R, Greene D, Stevens M, Burkhart N, Sandford T, Floyd J, Bantle J, Flaherty N, Terry J, Koozekanani D, Montezuma S, Wimmergren N, Rogness B, Mech M, Strand T, Olson J, McKenzie L, Kwong C, Goetz F, Warhol R, Hainsworth D, Goldstein D, Hitt S, Giangiacomo J, Schade D, Canady J, Burge M, Das A, Avery R, Ketai L, Chapin J, Schluter M, Rich J, Johannes C, Hornbeck D, Schutta M, Bourne P, Brucker A, Braunstein S, Schwartz S, Maschak‐Carey B, Baker L, Orchard T, Cimino L, Songer T, Doft B, Olson S, Becker D, Rubinstein D, Bergren R, Fruit J, Hyre R, Palmer C, Silvers N, Lobes L, Rath PP, Conrad P, Yalamanchi S, Wesche J, Bratkowksi M, Arslanian S, Rinkoff J, Warnicki J, Curtin D, Steinberg D, Vagstad G, Harris R, Steranchak L, Arch J, Kelly K, Ostrosaka P, Guiliani M, Good M, Williams T, Olsen K, Campbell A, Shipe C, Conwit R, Finegold D, Zaucha M, Drash A, Morrison A, Malone J, Bernal M, Pavan P, Grove N, Tanaka E, McMillan D, Vaccaro‐Kish J, Babbione L, Solc H, DeClue T, Dagogo‐Jack S, Wigley C, Ricks H, Kitabchi A, Chaum E, Murphy M, Moser S, Meyer D, Iannacone A, Yoser S, Bryer‐Ash M, Schussler S, Lambeth H, Raskin P, Strowig S, Basco M, Cercone S, Zinman B, Barnie A, Devenyi R, Mandelcorn M, Brent M, Rogers S, Gordon A, Bakshi N, Perkins B, Tuason L, Perdikaris F, Ehrlich R, Daneman D, Perlman K, Ferguson S, Palmer J, Fahlstrom R, de Boer I, Kinyoun J, Van Ottingham L, Catton S, Ginsberg J, McDonald C, Harth J, Driscoll M, Sheidow T, Mahon J, Canny C, Nicolle D, Colby P, Dupre J, Hramiak I, Rodger N, Jenner M, Smith T, Brown W, May M, Lipps Hagan J, Agarwal A, Adkins T, Lorenz R, Feman S, Survant L, White N, Levandoski L, Grand G, Thomas M, Joseph D, Blinder K, Shah G, Burgess D, Boniuk I, Santiago J, Tamborlane W, Gatcomb P, Stoessel K, Ramos P, Fong K, Ossorio P, Ahern J, Gubitosi‐Klug R, Meadema‐Mayer L, Beck C, Farrell K, Genuth S, Quin J, Gaston P, Palmert M, Trail R, Dahms W, Lachin J, Backlund J, Bebu I, Braffett B, Diminick L, Gao X, Hsu W, Klumpp K, Pan H, Trapani V, Cleary P, McGee P, Sun W, Villavicencio S, Anderson K, Dews L, Younes N, Rutledge B, Chan K, Rosenberg D, Petty B, Determan A, Kenny D, Williams C, Cowie C, Siebert C, Steffes M, Arends V, Bucksa J, Nowicki M, Chavers B, O'Leary D, Polak J, Harrington A, Funk L, Crow R, Gloeb B, Thomas S, O'Donnell C, Soliman E, Zhang Z, Li Y, Campbell C, Keasler L, Hensley S, Hu J, Barr M, Taylor T, Prineas R, Feldman E, Albers J, Low P, Sommer C, Nickander K, Speigelberg T, Pfiefer M, Schumer M, Moran M, Farquhar J, Ryan C, Sandstrom D, Williams T, Geckle M, Cupelli E, Thoma F, Burzuk B, Woodfill T, Danis R, Blodi B, Lawrence D, Wabers H, Gangaputra S, Neill S, Burger M, Dingledine J, Gama V, Sussman R, Davis M, Hubbard L, Budoff M, Darabian S, Rezaeian P, Wong N, Fox M, Oudiz R, Kim L, Detrano R, Cruickshanks K, Dalton D, Bainbridge K, Lima J, Bluemke D, Turkbey E, der Geest ., Liu C, Malayeri A, Jain A, Miao C, Chahal H, Jarboe R, Nathan D, Monnier V, Sell D, Strauch C, Hazen S, Pratt A, Tang W, Brunzell J, Purnell J, Natarajan R, Miao F, Zhang L, Chen Z, Paterson A, Boright A, Bull S, Sun L, Scherer S, Lopes‐Virella M, Lyons T, Jenkins A, Klein R, Virella G, Jaffa A, Carter R, Stoner J, Garvey W, Lackland D, Brabham M, McGee D, Zheng D, Mayfield R, Maynard J, Wessells H, Sarma A, Jacobson A, Dunn R, Holt S, Hotaling J, Kim C, Clemens Q, Brown J, McVary K. Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study. J Am Heart Assoc 2018. [PMCID: PMC6015340 DOI: 10.1161/jaha.117.008368] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background
Hyperglycemia leading to increased oxidative stress is implicated in the increased risk for the development of macrovascular and microvascular complications in patients with type 1 diabetes mellitus.
Methods and Results
A random subcohort of 349 participants was selected from the
DCCT
/
EDIC
(Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications) cohort. This included 320 controls and 29 cardiovascular disease cases that were augmented with 98 additional known cases to yield a case cohort of 447 participants (320 controls, 127 cases). Biosamples from
DCCT
baseline, year 1, and closeout of
DCCT
, and 1 to 2 years post‐
DCCT
(
EDIC
years 1 and 2) were measured for markers of oxidative stress, including plasma myeloperoxidase, paraoxonase activity, urinary F
2α
isoprostanes, and its metabolite, 2,3 dinor‐8
iso
prostaglandin F
2α
. Following adjustment for glycated hemoblobin and weighting the observations inversely proportional to the sampling selection probabilities, higher paraoxonase activity, reflective of antioxidant activity, and 2,3 dinor‐8
iso
prostaglandin F
2α
, an oxidative marker, were significantly associated with lower risk of cardiovascular disease (−4.5% risk for 10% higher paraoxonase,
P
<0.003; −5.3% risk for 10% higher 2,3 dinor‐8
iso
prostaglandin F
2α
,
P
=0.0092). In contrast, the oxidative markers myeloperoxidase and F
2α
isoprostanes were not significantly associated with cardiovascular disease after adjustment for glycated hemoblobin. There were no significant differences between
DCCT
intensive and conventional treatment groups in the change in all biomarkers across time segments.
Conclusions
Heightened antioxidant activity (rather than diminished oxidative stress markers) is associated with lower cardiovascular disease risk in type 1 diabetes mellitus, but these biomarkers did not change over time with intensification of glycemic control.
Clinical Trial Registration
URL
:
https://www.clinicaltrials.gov
. Unique identifiers:
NCT
00360815 and
NCT
00360893.
Collapse
Affiliation(s)
- W.H. Wilson Tang
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH
| | - Paula McGee
- The Biostatistics Center, George Washington University, Rockville, MD
| | - John M. Lachin
- The Biostatistics Center, George Washington University, Rockville, MD
| | - Daniel Y. Li
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
| | | | - Stanley L. Hazen
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Kostev K, Jacob L, Lucas A, Rathmann W. Low annual frequency of HbA 1c testing in people with Type 2 diabetes in primary care practices in Germany. Diabet Med 2018; 35:249-254. [PMID: 29178518 DOI: 10.1111/dme.13556] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/21/2017] [Indexed: 12/24/2022]
Abstract
AIMS To analyse the annual frequency of HbA1c testing, as well as the factors associated with higher or lower testing frequency, in people with Type 2 diabetes mellitus in general practices and specialist diabetes practices in Germany. METHODS A total of 43 509 people diagnosed with Type 2 diabetes between January 2016 and December 2016 in 557 medical practices (51% of all practices) were included in this study. The primary outcome was the annual recorded frequency of HbA1c testing in 2016. Multivariable logistic regression analyses were performed to identify variables associated with the odds of HbA1c concentration being tested at least twice in 2016, using predefined demographic and clinical variables. RESULTS The mean (sd) number of reported HbA1c tests was 2.7 (1.6) in 2016. Overall, 74% of individuals had at least two annual HbA1c measurements. The likelihood of receiving ≥2 HbA1c tests was inversely associated with stroke (odds ratio 0.81, 95% CI 0.74-0.89), shorter diabetes duration (≤1 year: odds ratio 0.77, 95% CI 0.70-0.84) and higher mean HbA1c concentration (≥8.5%: odds ratio 0.85, 95% CI 0.76-0.94) and was positively associated with specialist diabetes care (odds ratio 1.24, 95% CI 1.14-1.36), hypertension (odds ratio 1.10, 95% CI 1.04-1.17), hyperlipidaemia (odds ratio 1.48, 95% CI 1.41 to 1.55), renal complications (odds ratio 1.41, 95% CI 1.32 to 1.50), neuropathy (odds ratio 1.27, CI 1.20 to 1.35) and retinopathy (odds ratio 1.38, 95% CI 1.25 to 1.52). CONCLUSIONS Only three out of four individuals with Type 2 diabetes underwent at least two HbA1c tests in Germany in 2016, which means that 25% of individuals underwent fewer tests than required by German guidelines.
Collapse
Affiliation(s)
- K Kostev
- Epidemiology, IQVIA, Frankfurt, Germany
| | - L Jacob
- Faculty of Medicine, University of Paris 5, Paris, France
| | - A Lucas
- Faculty of Medicine, University of Marburg, Marburg, Germany
| | - W Rathmann
- Institute of Biometrics and Epidemiology, German Diabetes Centre, Leibniz Centre for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany
| |
Collapse
|
22
|
Abstract
Community-based rehabilitation is the strategy endorsed by the World Health Organization and other international bodies to promote the inclusion of people with disabilities, particularly in low- and middle-income countries. In this article we trace the journey of Edawu, a mental health rehabilitation unit in a rural area of Benue State, Nigeria, from an in-patient rehabilitation unit to a community-focused service. The partnership of organisations from the UK with Edawu along the journey is also described. The authors set out learning points from the project and the principles behind sustainable overseas organisational partnerships.
Collapse
Affiliation(s)
- N Chakraborty
- Consultant Psychiatrist, Leicestershire Partnership NHS Trust, UK; email
| | - A Erinfolami
- Consultant Psychiatrist and Head of the Department of Psychiatry, University of Lagos, Nigeria
| | - A Lucas
- Occupational Therapist, ACCEPT (mental health charity), UK
| |
Collapse
|
23
|
Cowen L, Mancini M, Lucas A, Martin A, Lavigne J, Donovan J. Utilization of corticosteroids in DuchenneConnect registry participants. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
24
|
Banuls J, Álvarez-Chinchilla PJ, Lucas A, Poveda I, Encabo-Durán B, Niveiro M, Nagore E, Zaballos P. Clinical, pathological and dermoscopic characteristics of cutaneous lesions in LEOPARD syndrome. J Eur Acad Dermatol Venereol 2017; 32:e100-e101. [PMID: 28862807 DOI: 10.1111/jdv.14573] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- J Banuls
- Dermatology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.,Medicina Clínica Department, Miguel Hernández University, Sant Joan D'Alacant, Alicante, Spain
| | - P J Álvarez-Chinchilla
- Dermatology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
| | - A Lucas
- Dermatology Department, Hospital General Universitario de Elda, Elda, Spain
| | - I Poveda
- Dermatology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
| | - B Encabo-Durán
- Dermatology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
| | - M Niveiro
- Pathology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
| | - E Nagore
- Dermatology Department, Instituto Valenciano de Oncología, Valencia, Spain
| | - P Zaballos
- Dermatology Department, Hospital Sant Pau i Santa Tecla, Tarragona, Spain
| |
Collapse
|
25
|
Gil-Gil M, Velarde J, Martinez-Garcia M, Gallego O, del Barco S, Pineda E, Mesia C, Estival A, Vilariño N, Marruecos J, Verger E, Craven J, Fuentes R, Lucas A, Macià M, Carrato C, Vidal N, Velasco R, Villa S, Balana C. Treatment of recurrent glioblastoma (GB) after radiotherapy (RT) and temozolomide (TMZ): A retrospective analysis of the GLIOCAT study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx366.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
26
|
Dunleavy K, Roschewski M, Abramson J, Link B, Parekh S, Jagadeesh D, Bierman P, Watson P, Peace D, Hanna W, Powell B, Melani C, Lucas A, Steinberg S, Kahl B, Friedberg J, Little R, Bartlett N, Fanale M, Noy A, Wilson W. RISK-ADAPTED THERAPY IN ADULTS WITH BURKITT LYMPHOMA: UPDATED RESULTS OF a MULTICENTER PROSPECTIVE PHASE II STUDY OF DA-EPOCH-R. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_122] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- K. Dunleavy
- Center for Cancer Research; National Cancer Institute; Bethesda USA
| | - M. Roschewski
- Center for Cancer Research; National Cancer Institute; Bethesda USA
| | - J.S. Abramson
- Center for Lymphoma; Massachusetts General Hospital; Boston USA
| | - B. Link
- Hematology-Oncology; University of Iowa Hospitals; Iowa City USA
| | - S. Parekh
- Hematology-Oncology; Icahn School of Medicine at Mount Sinai; New Yorki USA
| | - D. Jagadeesh
- Hematology-Oncology; Cleveland Clinic; Cleveland USA
| | - P. Bierman
- Hematology-Oncology; University of Nebraska Medical Center; Omaha USA
| | - P.R. Watson
- Hematology-Oncology; Kinston Medical Specialists; Kinston USA
| | - D. Peace
- Hematology-Oncology; University of Illinois; Chicago USA
| | - W. Hanna
- Hematology-Oncology; University of Tennessee Medical Center; Knoxville USA
| | - B. Powell
- Hematology-Oncology; Comprehensive Cancer Center of Wake Forest University; Winston-Salem USA
| | - C. Melani
- Center for Cancer Research; National Cancer Institute; Bethesda USA
| | - A. Lucas
- Center for Cancer Research; National Cancer Institute; Bethesda USA
| | - S.M. Steinberg
- Center for Cancer Research; National Cancer Institute; Bethesda USA
| | - B. Kahl
- Hematology-Oncology; Washington University; St. Louis USA
| | - J.W. Friedberg
- Hematology-Oncology; University of Rochester; Rochester USA
| | - R.F. Little
- Cancer Therapy Evaluation Program; National Cancer Institute; Rockville USA
| | - N.L. Bartlett
- Hematology-Oncology; Washington University; St. Louis USA
| | - M.A. Fanale
- Hematology-Oncology; MD Anderson Cancer Center; Houston USA
| | - A. Noy
- Hematology-Oncology; Memorial Sloan Kettering Cancer Center; New York USA
| | - W.H. Wilson
- Center for Cancer Research; National Cancer Institute; Bethesda USA
| |
Collapse
|
27
|
Salas Q, Domingo Domenech E, Mercadal S, Oliveira A, Aguilera C, De la Banda E, Climent F, Lucas A, Garcia N, Baca C, Fernandez de Sevilla A, Sureda A, González Barca E. Effective treatments are required for patients with diffuse large B-cell lymphoma (DLBCL) with primary refractory disease. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_92] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Q.Q. Salas
- Hematology Department; Institut Català d'Oncologia Hospitalet, Hospitalet del LLobregat; Barcelona Spain
| | - E. Domingo Domenech
- Hematology Department; Institut Català d'Oncologia Hospitalet, Hospitalet del LLobregat; Barcelona Spain
| | - S. Mercadal
- Hematology Department; Institut Català d'Oncologia Hospitalet, Hospitalet del LLobregat; Barcelona Spain
| | - A. Oliveira
- Hematology Department; Institut Català d'Oncologia Hospitalet, Hospitalet del LLobregat; Barcelona Spain
| | - C. Aguilera
- Hematology Department; Institut Català d'Oncologia Hospitalet, Hospitalet del LLobregat; Barcelona Spain
| | - E. De la Banda
- Pathology Department; Hospital Universitario de Bellvitge, IDIBELL, Hospitalet del LLobregat; Barcelona Spain
| | - F. Climent
- Pathology Department; Hospital Universitario de Bellvitge, IDIBELL, Hospitalet del LLobregat; Barcelona Spain
| | - A. Lucas
- Hematology Department; Institut Català d'Oncologia Hospitalet, Hospitalet del LLobregat; Barcelona Spain
| | - N. Garcia
- Hematology Department; Institut Català d'Oncologia Hospitalet, Hospitalet del LLobregat; Barcelona Spain
| | - C. Baca
- Hematology Department; Institut Català d'Oncologia Hospitalet, Hospitalet del LLobregat; Barcelona Spain
| | - A. Fernandez de Sevilla
- Department of Hematology, Institut Català d'Oncologia Hospitalet, IDIBELL, Barcelona, Spain. IDIBELL. Departament of Clinical Sciences; University of Barcelona, Hospitalet del LLobregat; Barcelona Spain
| | - A. Sureda
- Hematology Department; Institut Català d'Oncologia Hospitalet, Hospitalet del LLobregat; Barcelona Spain
| | - E. González Barca
- Department of Hematology, Institut Català d'Oncologia Hospitalet, IDIBELL, Barcelona, Spain. IDIBELL. Departament of Clinical Sciences; University of Barcelona, Hospitalet del LLobregat; Barcelona Spain
| |
Collapse
|
28
|
Gindre J, Bel-Brunon A, Rochette M, Lucas A, Kaladji A, Haigron P, Combescure A. Patient-Specific Finite-Element Simulation of the Insertion of Guidewire During an EVAR Procedure: Guidewire Position Prediction Validation on 28 Cases. IEEE Trans Biomed Eng 2017; 64:1057-1066. [DOI: 10.1109/tbme.2016.2587362] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
29
|
Jalaguier S, Teyssier C, Nait Achour T, Lucas A, Bonnet S, Rodriguez C, Elarouci N, Lapierre M, Cavaillès V. Complex regulation of LCoR signaling in breast cancer cells. Oncogene 2017; 36:4790-4801. [PMID: 28414308 PMCID: PMC5562849 DOI: 10.1038/onc.2017.97] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2016] [Revised: 01/18/2017] [Accepted: 02/24/2017] [Indexed: 12/15/2022]
Abstract
Ligand-dependent corepressor (LCoR) is a transcriptional repressor of ligand-activated estrogen receptors (ERs) and other transcription factors that acts both by recruiting histone deacetylases and C-terminal binding proteins. Here, we first studied LCOR gene expression in breast cancer cell lines and tissues. We detected two mRNAs variants, LCoR and LCoR2 (which encodes a truncated LCoR protein). Their expression was highly correlated and localized in discrete nuclear foci. LCoR and LCoR2 strongly repressed transcription, inhibited estrogen-induced target gene expression and decreased breast cancer cell proliferation. By mutagenesis analysis, we showed that the helix-turn-helix domain of LCoR is required for these effects. Using in vitro interaction, coimmunoprecipitation, proximity ligation assay and confocal microscopy experiments, we found that receptor-interacting protein of 140 kDa (RIP140) is a LCoR and LCoR2 partner and that this interaction requires the HTH domain of LCoR and RIP140 N- and C-terminal regions. By increasing or silencing LCoR and RIP140 expression in human breast cancer cells, we then showed that RIP140 is necessary for LCoR inhibition of gene expression and cell proliferation. Moreover, LCoR and RIP140 mRNA levels were strongly correlated in breast cancer cell lines and biopsies. In addition, RIP140 positively regulated LCoR expression in human breast cancer cells and in transgenic mouse models. Finally, their expression correlated with overall survival of patients with breast cancer. Taken together, our results provide new insights into the mechanism of action of LCoR and RIP140 and highlight their strong interplay for the control of gene expression and cell proliferation in breast cancer cells.
Collapse
Affiliation(s)
- S Jalaguier
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.,INSERM, U1194, Montpellier, France.,Université de Montpellier, Montpellier, France.,Institut régional du Cancer de Montpellier, Montpellier, France
| | - C Teyssier
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.,INSERM, U1194, Montpellier, France.,Université de Montpellier, Montpellier, France.,Institut régional du Cancer de Montpellier, Montpellier, France
| | - T Nait Achour
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.,INSERM, U1194, Montpellier, France.,Université de Montpellier, Montpellier, France.,Institut régional du Cancer de Montpellier, Montpellier, France
| | - A Lucas
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.,INSERM, U1194, Montpellier, France.,Université de Montpellier, Montpellier, France.,Institut régional du Cancer de Montpellier, Montpellier, France
| | - S Bonnet
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.,INSERM, U1194, Montpellier, France.,Université de Montpellier, Montpellier, France.,Institut régional du Cancer de Montpellier, Montpellier, France
| | - C Rodriguez
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.,INSERM, U1194, Montpellier, France.,Université de Montpellier, Montpellier, France.,Institut régional du Cancer de Montpellier, Montpellier, France
| | - N Elarouci
- Programme Cartes d'Identité des Tumeurs (CIT), Ligue Nationale Contre Le Cancer, Paris, France
| | - M Lapierre
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.,INSERM, U1194, Montpellier, France.,Université de Montpellier, Montpellier, France.,Institut régional du Cancer de Montpellier, Montpellier, France
| | - V Cavaillès
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.,INSERM, U1194, Montpellier, France.,Université de Montpellier, Montpellier, France.,Institut régional du Cancer de Montpellier, Montpellier, France
| |
Collapse
|
30
|
Fewtrell MS, Kennedy K, Ahluwalia JS, Nicholl R, Lucas A, Burton P. Predictors of expressed breast milk volume in mothers expressing milk for their preterm infant. Arch Dis Child Fetal Neonatal Ed 2016; 101:F502-F506. [PMID: 26936878 DOI: 10.1136/archdischild-2015-308321] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/27/2015] [Revised: 09/21/2015] [Accepted: 02/10/2016] [Indexed: 11/03/2022]
Abstract
BACKGROUND An understanding of predictors of breast milk production may enable the provision of better advice and support to mothers with preterm infants who may need to express milk for long periods. OBJECTIVE To investigate factors predicting the amount of milk expressed by mothers for their preterm infant (1) during the first 10 days and (2) during the infant's whole hospital stay. METHODS 62 mothers with preterm infants <34 weeks who participated in a randomised trial comparing two breast pumps completed 10-day diaries including weight of milk expressed and questionnaires giving their opinion of the breast pump; 47 mothers provided data on milk expression up to the infant's hospital discharge. RESULTS Significant predictors of 10-day milk weight in multivariate models were the number of episodes of 'breast feeding' (17 g (95% CI 8 to 26, p=0.001) increase per episode), the use of double versus single pumping (109 (31-186, p=0.007) g/day more) and the number of complete daily records (17 (1-33, p=0.04) g increase/day). Significant multivariate predictors of total milk production were double versus single pumping (491 (55) mL/day vs 266 (44) mL/day), expressing 500 mL/day by day 10 (525 (53) mL/day vs 232 (43) mL/day) and a higher score for breast pump 'comfort' (best=489 (39) mL/day, middle=335 (57) mL/day, worst=311 (78) mL/day). CONCLUSIONS These results suggest that relatively simple, modifiable factors can favourably impact milk production in the neonatal intensive care unit setting and emphasise the importance of double pumping, early establishment of milk production and design features of the breast pump that promote comfort. TRIAL REGISTRATION NUMBER NCT00887991.
Collapse
Affiliation(s)
- M S Fewtrell
- Childhood Nutrition Research Centre, UCL Institute of Child Health, London, UK
| | - K Kennedy
- Childhood Nutrition Research Centre, UCL Institute of Child Health, London, UK
| | - J S Ahluwalia
- Neonatal Intensive Care Unit, Addenbrookes Hospital, Cambridge, UK
| | - R Nicholl
- Neonatal Intensive Care Unit (NICU), Northwick Park Hospital, Harrow, Middlesex, UK
| | - A Lucas
- Childhood Nutrition Research Centre, UCL Institute of Child Health, London, UK
| | - P Burton
- Childhood Nutrition Research Centre, UCL Institute of Child Health, London, UK
| |
Collapse
|
31
|
Martinez-Garcia M, Pineda E, Del Barco S, Estival A, Verger E, Marruecos J, Gallego O, Gil M, Fuentes R, de Grigno JCBL, Lucas A, Macia M, Mesía C, Velarde J, García N, Villà S, Balana C. Concomitant chemoradiation (Ch-RT) in elderly newly diagnosed glioblastoma (GB) patients. Updated clinical outcome and molecular characteristics from the GLIOCAT study. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw367.23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
32
|
Estival A, Pineda E, Martinez-Garcia M, Marruecos J, Mesía C, Lucas A, Macia M, Gil M, Gallego O, Verger E, Del Barco S, Fuentes R, Craven J, García N, Villà S, Velarde J, Carrato C, Ribalta T, Arpi O, Balana C. MGMT methylated (Met) patients (p) with glioblastoma (GBM) have a better prognosis with an earlier response (ER) than those who have a late response or pseudoprogression (LR/PsP). Results of the Gliocat study. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw367.16] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
33
|
Izquierdo C, Vidal N, Ruiz N, Plans G, Lucas A, Macià M, Majós C, Simó M, Gil-Gil M, Bruna J. P11.07 Atypical Meningioma: The impact of WHO 2007 criteria. Neuro Oncol 2016. [DOI: 10.1093/neuonc/now188.238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
34
|
Linares J, Stradella A, Pernas S, Ortega A, Galdeano M, Lucas A, Macia M, Vidal N, Morilla I, Sabela R, Falo C, Velasco R, Gil-Gil M. Breast-GPA and type of treatment predictors of survival in brain metastasis patients. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw365.36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
35
|
Ambadapadi S, Chen H, Fuentes J, Morshed S, Davids J, Marques B, Lucas A. Cross-class serine protease inhibitor Serp-2 blocks liver ischemia reperfusion injury. Atherosclerosis 2016. [DOI: 10.1016/j.atherosclerosis.2016.07.436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
36
|
Gilles HM, Lucas A, Lindner R, Cockshott WP, Anand SV, Ikeme A, Cowper SG. Schistosoma haematobiuminfection in Nigeria. Annals of Tropical Medicine & Parasitology 2016. [DOI: 10.1080/00034983.1965.11686331] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
37
|
Gilles HM, Lucas A, Adeniyi-Jones C, Lindner R, Anand SV, Braband H, Cockshott WP, Cowper SG, Muller RL, Hira PR, Wilson AMM. Schistosoma haematobiuminfection in Nigeria. Annals of Tropical Medicine & Parasitology 2016. [DOI: 10.1080/00034983.1965.11686330] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|
38
|
Tornambé G, Lucas A, Verdier-Metz I, Hulin S, Agabriel C, Martin B. Effect of production systems on sensory characteristics of PDO Cantal cheese. Italian Journal of Animal Science 2016. [DOI: 10.4081/ijas.2005.2s.248] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
39
|
Priegue M, Vila A, Lucas A, Calonge M, Parrilla A. DI-078 Economic impact evaluation of oseltamivir adjustment criteria in renal impairment. Eur J Hosp Pharm 2016. [DOI: 10.1136/ejhpharm-2016-000875.344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
40
|
Kalsi P, Turkistani W, Sykes C, Lucas A, Zarnegar R. “Work is a beautiful thing....” Exploring attitudes towards employment in chronic pain (CP) patients attending a pain management programme (PMP). JVR 2016. [DOI: 10.3233/jvr-150783] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- P. Kalsi
- City University London, London, UK
| | | | | | - A. Lucas
- Royal National Orthopaedic Hospital, Stanmore, UK
| | - R. Zarnegar
- Royal National Orthopaedic Hospital, Stanmore, UK
| |
Collapse
|
41
|
Fabris V, Junqueira J, Silva M, Mallmann F, Oliveira G, Lucas A. Avaliação do Conhecimento dos Cirurgiões-Dentistas sobre Suporte Básico de Vida Frente a Emergências Médicas em Odontologia. J Oral Invest 2015. [DOI: 10.18256/2238-510x/j.oralinvestigations.v4n2p50-56] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
42
|
Salvador C, Gómez ON, Ripoll J, Barbosa G, Hervás D, Bataller L, Bernisz Y, Ferrer J, Lucas A, Prat R, Reynés G. 2914 Neuro-oncology information system: A comprehensive tool to improve quality of care. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31629-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
43
|
Gindre J, Bel-Brunon A, Combescure A, Haigron P, Rochette M, Lucas A. Estimation of clinically relevant indicators for EVAR using patient-specific finite element simulation. Comput Methods Biomech Biomed Engin 2015; 18 Suppl 1:1950-1. [PMID: 26230314 DOI: 10.1080/10255842.2015.1069552] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- J Gindre
- a LaMCoS , UMR CNRS 5259/ INSA-LYON , Villeurbanne , France.,c ANSYS France , Montigny-le-Bretonneux , France
| | - A Bel-Brunon
- a LaMCoS , UMR CNRS 5259/ INSA-LYON , Villeurbanne , France
| | - A Combescure
- a LaMCoS , UMR CNRS 5259/ INSA-LYON , Villeurbanne , France
| | - P Haigron
- b LTSI , Université Rennes 1/ INSERM U1099 , Rennes , France
| | - M Rochette
- c ANSYS France , Montigny-le-Bretonneux , France
| | - A Lucas
- d CHU Rennes , Service de Chirurgie Vasculaire , Rennes , France
| |
Collapse
|
44
|
Ambadapadi S, Zheng D, Munaswamy-Ramanujam G, Lucas A. Serine protease inhibitor (serpin) reactive center loop peptides as therapy for inflammatory vasculitis, hemorrhage and acute viral sepsis. Atherosclerosis 2015. [DOI: 10.1016/j.atherosclerosis.2015.04.994] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
45
|
Zheng D, Ambadapadi S, Chen H, Wakefield D, Clapp W, Lucas A. Inhibition of chemokine:glycosaminoglycan (GAG) (glycocalyx) interaction in the donor kidney significantly reduces transplant rejection and vascular inflammation. Atherosclerosis 2015. [DOI: 10.1016/j.atherosclerosis.2015.04.911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
46
|
Scott R, Dooley S, Lewis W, Meldrum C, Pockney P, Draganic B, Smith S, Jones F, Hewitt C, Phillimore H, Lucas A, Shi E, Namdarian K, Chan T, Acosta D, Chan SP, Fox S. P-273 Concordance of RAS mutation status in CRC patients by comparison of results from circulating tumour DNA and tissue-based testing. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv233.270] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
47
|
Blasques F, Koopman SJ, Lucas A. Information-theoretic optimality of observation-driven time series models for continuous responses. Biometrika 2015. [DOI: 10.1093/biomet/asu076] [Citation(s) in RCA: 72] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
48
|
Izquierdo C, Majos C, Simo M, Lucas A, Macia M, Plans G, Gil M, Velasco R, Bruna J. O8.03 * LOW GRADE DIFFUSE ASTROCYTOMA - PROGNOSTIC FACTORS TO ANAPLASTIC TRANSFORMATION. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou174.64] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
Premakumari V, Chukkapalli S, Rivera M, Velsko I, Phillippi J, Gleason T, Lucas A, Beaver T, Chan E, Kesavalu L. Microrna expression signature in human thoracic and abdominal aortic aneurysms. Atherosclerosis 2014. [DOI: 10.1016/j.atherosclerosis.2014.05.363] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
50
|
Lucas A, Mialet-Perez J, Lezoualc′h F, Parini A, Marber M, Sicard P. P142Gadd45 gamma regulates cardiomyocytes death and post-myocardial infarction left ventricular remodeling. Cardiovasc Res 2014. [DOI: 10.1093/cvr/cvu082.81] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|